farmaecFARMAKOEKONOMIKA. Modern Pharmacoeconomics and PharmacoepidemiologyФАРМАКОЭКОНОМИКА. Современная фармакоэкономика и фармакоэпидемиология2070-49092070-4933IRBIS LLC10.17749/2070-4909.2016.9.4.046-053farmaec-168Research ArticleForeign ExperienceЗарубежный опытCOMPARISON OF RECOMMENDED SCREENING PROGRAMS IN THE UNITED STATES, CANADA, THE NETHERLANDS AND GERMANYСравнение рекомендуемых скрининговых программ в США, Канаде, Нидерландах и ГерманииДомбровскийВ. С.DombrovskiyV. S.

научный сотрудник Лаборатории оценки технологий в здравоохранении Института прикладных экономических исследований Российской академии народного хозяйства и государственной службы при Президенте РФ. Адрес: проспект Вернадского, д. 82 стр. 1, Москва, Россия, 119571. Тел.: +7(499)9569528

researcher at the Laboratory for Health Technology Assessment at the Institute of Applied Economic Research of the Russian Presidential Academy of National Economy and Public Administration. Address: Vernadskogo prospect, 82-1, Moscow, Russia, 119571. Tel.: +7(499)9569528

dombrovlad@gmail.comХачатрянГ. Р.KhachatryanG. R.

научный сотрудник Лаборатории оценки технологий здравоохранения Института прикладных экономических исследований Российской академии народного хозяйства и государственной службы при Президенте РФ, младший научный сотрудник Центра финансов здравоохранения Научно-исследовательского финансового института Министерства финансов РФ. Адрес: проспект Вернадского, д. 82 стр.1, Москва, Russia, 119571. Тел.: +7(499)9569528

researcher at the Laboratory for Health Technology Assessment at the Institute of Applied Economic Research of the Russian Presidential Academy of National Economy and Public Administration, junior researcher of the Center for Healthcare Funding of the Financial Scientific Research Institute at the Ministry of Finance of the Russian Federation. Address: Vernadskogo prospect, 82-1, Moscow, Russia, 119571. Tel.: +7(499)9569528

gkh@hta-rus.ruФГБОУ ВПО «Российская академия народного хозяйства и государственной службы при Президенте Российской Федерации»РоссияThe Russian Presidential Academy of National Economy and Public AdministrationRussian FederationФГБОУ ВПО «Российская академия народного хозяйства и государственной службы при Президенте Российской Федерации» ФГБУ «Научно-исследовательский финансовый институт» Министерства финансов Российской ФедерацииРоссияThe Russian Presidential Academy of National Economy and Public Administration Research Institute of Finance, Ministry of Finance of the Russian FederationRussian Federation201613032017944653Copyright © Dombrovskiy V.S., Khachatryan G.R., 20172017Домбровский В.С., Хачатрян Г.Р.Dombrovskiy V.S., Khachatryan G.R.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.pharmacoeconomics.ru/jour/article/view/168

This publication presents a comparison of recommendations of screening programs and prevention activities in the United States, Canada, the Netherlands and Germany for adult non-pregnant population excluding infectious diseases. Sources of funding for such programs and information about their implementation are descripted. According to the search results of the relevant information in open sources, a list of recommended screening programs, as well as the amount of available information describing these programs in foreign countries varies.

В данной публикации представлено сравнение рекомендаций скрининговых программ и профилактических мероприятий в США, Канаде, Нидерландах и Германии для взрослого небеременного населения, за исключением инфекционных заболеваний. Рассматриваются источники финансирования таких программ и сведения об их реализации на территории страны. По итогам поиска соответствующей информации в открытых источниках установлено, что в развитых зарубежных странах варьируется как перечень рекомендуемых скрининговых программ, так и объем доступных сведений, описывающих такие программы.

Скринингпрофилактикадиспансеризациярекомендациимеждународный опыт.Screeningpreventionexaminationsrecommendationsinternational experienceReferencesАвксентьева М. В., Омельяновский В. В. Международный опыт оценки технологий в здравоохранении. Медицинские технологии. Оценка и выбор. 2010; 1: 52-58.Avksent’eva M. V., Omel’yanovskii V. V. Meditsinskie tekhnologii. Otsenka i vybor. 2010; 1: 52-58.Пядушкина Е. А., Авксентьева М. В., Омельяновский В. В. Зарубежные рекомендации по раннему выявлению хронических неинфекционных заболеваний: опыт Великобритании и США. Медицинские технологии. Оценка и выбор. 2016; 3: 20-33.Pyadushkina E. A., Avksent’eva M. V., Omel’yanovskii V. V. Meditsinskie tekhnologii. Otsenka i vybor. 2016; 3: 20-33.Что такое Medicare? URL: https://www.medicare.gov/pubs/pdf/other-languages-not-sp/11306-R.pdf. Дата обращения: 25.11.2016Chto takoe Medicare? URL: https://www.medicare.gov/pubs/pdf/other-languages-not-sp/11306-R.pdf. Accessed: 25.11.2016Andermann A., Blancquaert I., Beauchamp S., Dйry V. Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years. Bull World Health Organ. 2008; 86 (4): 317-319. URL: http://www.who.int/bulletin/volumes/86/4/07-050112/en/. Дата обращения: 25.11.2016Andermann A., Blancquaert I., Beauchamp S., Dйry V. Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years. Bull World Health Organ. 2008; 86 (4): 317-319. URL: http://www.who.int/bulletin/volumes/86/4/07- 050112/en/. Accessed: 25.11.2016Atrial Fibrillation. URL: http://canadiantaskforce.ca/appraised-guidelines/2014-atrial- fibrillation/. Дата обращения: 25.11.2016Atrial Fibrillation. URL: http://canadiantaskforce.ca/appraised-guidelines/2014-atrial-fibrillation/. Accessed: 25.11.2016Colorectal Cancer (2016). URL: http://canadiantaskforce.ca/ctfphc-guidelines/2015- colorectal-cancer/. Дата обращения: 25.11.2016Colorectal Cancer (2016). URL: http://canadiantaskforce.ca/ctfphc-guidelines/2015-colorectal-cancer/. Accessed: 25.11.2016Early detection examinations covered by statutory health insurance. URL: http://www.english.g-ba.de/special-topics/prevention/detection/. Дата обращения: 25.11.2016Early detection examinations covered by statutory health insurance. URL: http://www.english.g-ba.de/special-topics/prevention/detection/. Accessed: 25.11.2016Holland W. W., Stewart S. Screening in Disease Prevention: What Works? Oxford: Radcliffe Publishing Ltd in association with The Nuffield Trust and the European Observatory on Health Systems and Policies. 2005. URL: http://www.euro.who.int/__data/assets/pdf_file/0007/108961/E88698.pdf. Дата обращения: 25.11.2016Holland W. W., Stewart S. Screening in Disease Prevention: What Works? Oxford: Radcliffe Publishing Ltd in association with The Nuffield Trust and the European Observatory on Health Systems and Policies. 2005. URL: http://www.euro.who.int/__data/assets/pdf_file/0007/108961/E88698.pdf. Accessed: 25.11.2016Lung Cancer (2016). URL: http://canadiantaskforce.ca/ctfphc-guidelines/2015-lung- cancer/. Дата обращения: 25.11.2016Lung Cancer (2016). URL: http://canadiantaskforce.ca/ctfphc-guidelines/2015-lung- cancer/. Accessed: 25.11.2016Melanoma. URL: http://canadiantaskforce.ca/appraised-guidelines/2013-melanoma/. Дата обращения: 25.11.2016Melanoma. URL: http://canadiantaskforce.ca/appraised-guidelines/2013-melanoma/. Accessed: 25.11.2016Obesity in Adults (2015). URL: http://canadiantaskforce.ca/ctfphc-guidelines/2015- obesity-adults/. Дата обращения: 25.11.2016Obesity in Adults (2015). URL: http://canadiantaskforce.ca/ctfphc-guidelines/2015-obesity-adults/. Accessed: 25.11.2016Osteoporosis. URL: http://canadiantaskforce.ca/appraised-guidelines/2013-osteoporosis/. Дата обращения: 25.11.2016Osteoporosis. URL: http://canadiantaskforce.ca/appraised-guidelines/2013-osteoporosis/. Accessed: 25.11.2016Population Screening Act: Renewal of nationwide cervical cancer screening programme. URL: https://www.gezondheidsraad.nl/en/task-and-procedure/areas-of- activity/prevention/population-screening-act-renewal-of-nationwide. Дата обращения: 25.11.2016Population Screening Act: Renewal of nationwide cervical cancer screening programme. URL: https://www.gezondheidsraad.nl/en/task-and-procedure/areas-of- activity/prevention/population-screening-act-renewal-of-nationwide. Accessed: 25.11.2016Population Screening Act: study of faecal tests within the population based screening programme for colorectal cancer. URL: https://www.gezondheidsraad.nl/en/task-and-procedure/areas-of-activity/prevention/population-screening-act-study-of-faecal-tests. Дата обращения: 25.11.2016Population Screening Act: study of faecal tests within the population based screening programme for colorectal cancer. URL: https://www.gezondheidsraad.nl/en/task-and-procedure/areas-of-activity/prevention/population-screening-act-study-of-faecal-tests. Accessed: 25.11.2016Population Screening Act: pressureguided compression for breast cancer screening. URL: https://www.gezondheidsraad.nl/en/task-and-procedure/areas-of- activity/prevention/population-screening-act-pressureguided-compression. Дата обращения: 25.11.2016Population Screening Act: pressureguided compression for breast cancer screening. URL: https://www.gezondheidsraad.nl/en/task-and-procedure/areas-of-activity/prevention/population-screening-act-pressureguided-compression. Accessed: 25.11.2016Preventive & screening services. URL: https://www.medicare.gov/coverage/preventive-and-screening-services.html. Дата обращения: 25.11.2016Preventive & screening services. URL: https://www.medicare. gov/coverage/preventive-and-screening-services.html. Accessed: 25.11.2016Screening for Breast Cancer (2011). URL: http://canadiantaskforce.ca/ctfphc- guidelines/2011-breast-cancer/. Дата обращения: 25.11.2016Screening for Breast Cancer (2011). URL: http://canadiantaskforce.ca/ctfphc- guidelines/2011-breast-cancer/. Accessed: 25.11.2016Screening for Cervical Cancer (2013). URL: http://canadiantaskforce.ca/ctfphc- guidelines/2013-cervical-cancer/. Дата обращения: 25.11.2016Screening for Cervical Cancer (2013). URL: http://canadiantaskforce.ca/ctfphc- guidelines/2013-cervical-cancer/. Accessed: 25.11.2016Screening for Depression (2013). URL: http://canadiantaskforce.ca/ctfphc- guidelines/2013-depression/. Дата обращения: 25.11.2016Screening for Depression (2013). URL: http://canadiantaskforce.ca/ctfphc- guidelines/2013-depression/. Accessed: 25.11.2016Screening for Hypertension (2012). URL: http://canadiantaskforce.ca/ctfphc- guidelines/2012-hypertension/. Дата обращения: 25.11.2016Screening for Hypertension (2012). URL: http://canadiantaskforce.ca/ctfphc-guidelines/2012-hypertension/. Accessed: 25.11.2016Screening for Prostate Cancer (2014). URL: http://canadiantaskforce.ca/ctfphc- guidelines/2014-prostate-cancer/. Дата обращения: 25.11.2016Screening for Prostate Cancer (2014). URL: http://canadiantaskforce.ca/ctfphc-guidelines/2014-prostate-cancer/. Accessed: 25.11.2016Screening for Type 2 Diabetes (2012). URL: http://canadiantaskforce.ca/ctfphc- guidelines/2012-type-2-diabetes/. Дата обращения: 25.11.2016Screening for Type 2 Diabetes (2012). URL: http://canadiantaskforce.ca/ctfphc- guidelines/2012-type-2-diabetes/. Accessed: 25.11.2016Seedat F., Cooper J., Stranges S., Kandala N. B., Taylor-Phillips S. International comparisons of screening policy-making: A systematic review. National Screening Committee. 2014. URL: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/444227/FI NAL_REPORT_International_Screening.pdf. Дата обращения: 25.11.2016Seedat F., Cooper J., Stranges S., Kandala N. B., Taylor-Phillips S. International comparisons of screening policy-making: A systematic review. National Screening Committee. 2014. URL: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/444227/FI NAL_REPORT_International_Screening.pdf. Accessed: 25.11.2016USPSTF A and B Recommendations. U. S. Preventive Services Task Force. April 2016. URL: http://www.uspreventiveservicestaskforce.org/Page/Name/uspstf-a-and-b- recommendations/. Дата обращения: 25.11.2016USPSTF A and B Recommendations. U. S. Preventive Services Task Force. April 2016. URL: http://www.uspreventiveservicestaskforce.org/Page/Name/uspstf-a-and-b- recommendations/. Accessed: 25.11.2016

The authors declare that there are no conflicts of interest present.